PharmaVOICE - 
February 2003
Purchase Issue

In Every Issue
Talent Pool
Pharma POOL Dr. Peter KRUSE Tom MARTIN Dr. Brett E. [...]
By
E-Media
84 F e b ru a r y 200 3 [...]
By
What’s New
WHAT’S NEW NEW HEALTHCARERELATED PRODUCTS, SERVICES, AND COMPANIES Pharmaceutical companies [...]
By
On the Calendar
February 10,2003,Park Hyatt San Francisco — San Francisco European Regulatory [...]
By
PharmaTrax
Survey Shows One Third of Americans USE ANTIBIOTICS INAPPROPRIATELY A [...]
By
For Art’s Sake
CREATIVE REVIEW One of my goals at RealAge is to show [...]
By
PharmaOutlet
When launching a newproduct, marketers tend to focus on core [...]
By
What’s on Your Mind: Opinions
A bold, broad, unapologetic proclamation of benefits The most significant [...]
By
Letter from the Editor
PUBLISHER Lisa Banket EDITOR Taren Grom CREATIVE DIRECTOR Marah Walsh [...]
By

On The Cover

A Value Proposition: Managing the Supply Chain
*Solutions that encompass the strategy, processes, people, technologies, and resources responsible for ensuring the flow of materials and services are necessary to deliver an organization’s value to its end-user customers.* MANAGING INVENTORIES, WORKING CLOSELY WITH CONTRACTED SUPPLIERS TO ENSURE DELIVERIES, AND ENSURING THAT HEALTHCARE PROFESSIONALS HAVE PREFERRED MATERIALS ARE ALL CRUCIAL,BEHIND THE SCENES ELEMENTS TO A COMPANY’S [...]
By

Denise Myshko

Features

From Scorpion to Cancer
MOTHER NATURE BUILT IT, MAN IS IMPROVING IT. TransMolecular’s 131 ITM601 is a synthetic version of a peptide from the venom of scorpions combined with a radioactive iodine. In Phase I/II trials to treat glioma,a deadly form of brain cancer, the product can deliver a targeted dose of radiation to cancerous cells without affecting normal [...]
By

Denise Myshko

After 20 Years of DTC, It’s Time for a New Definition
54 F e b ru a r y 200 3 PharmaVOICE S THE NEW YEAR BEGINS TO UNFOLD, the pharmaceuti cal industry continues to face challenges on many fronts. Corpo rate profits are down, R&D pipelines have slowed, Washington politicians haven’t eased their attacks, and public perception is near an alltime low. With big pharma [...]
By
Piecing Together the Privacy Puzzle
As healthcare providers PREPARE TO COMPLY with the PATIENT PRIVACY ISSUES stemming from the HEALTH INFORMATION PORTABILITY AND ACCOUNTABILITY ACT, the pharmaceutical industry will have to FIND WAYS TO WORK with business partners within the CONFINES OF THE LAW if they want to continue to gain access to data. Starting in April 2003 patients will [...]
By

Kim Ribbink

Net Returns — An Integrated Approach to Marketing
An Integrated Approach to Marketing FOLLOWING THE HYPE AND QUICK UPTAKE THAT MARKED THE INTERNET EXPLOSION OF THE LATE 1990S, MANY COMPANIES STEPPED BACK FROM THE MEDIUM. AS THE INTERNET CONTINUES TO MATURE AS A COMMUNICATIONS VEHICLE, THE HEALTHCARE INDUSTRY IS RETURNING TO THE WEB AND INTEGRATING ONLINE INITIATIVES AS PART OF THE MARKETING PLAN. [...]
By

Elisabeth Pena

FEEDBACK